Clinical Trial

A Sub Study to Investigate the Safety and Tolerability of Aletekitug in Participants With Moderate To Severe Ulcerative Colitis

Name: A Sub Study to Investigate the Safety and Tolerability of Aletekitug in Participants With Moderate To Severe Ulcerative Colitis — clinical trial record (NCT07747480)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This goal of this sub-study is to learn how safe and tolerable the study drug, aletekitug (anti-IL-18), in participants with moderately to severely active ulcerative colitis (UC). This study is the sub-study of the platform trial.

Trial Details

NCT Number	NCT07747480
Lead Sponsor	GlaxoSmithKline
Conditions	Colitis, Ulcerative
Enrollment	16 participants
Start Date	2026-08-10
Primary Completion	2028-07-31 (estimated)
Study Completion	2028-12-04 (estimated)
Updated on ClinicalTrials.gov	2026-08-05